PHARMACY

The bill, which requires electronic prescribing of Schedules I through VI controlled substances, goes into effect Jan. 1, 2021.

Despite seeing revenue growth from its recently launched PBM segment and increases in revenue and gross profits, Diplomat Pharmacy posted a net loss of $298 million for the fourth quarter.

Zydus Cadila's generic Janumet will give Type 2 diabetes patients another treatment option.

Francesco Balestrieri has been named as interim CEO of Sandoz as Richard Francis steps down as Sandoz CEO.

In addition to DIR fee reform, NACDS also is urging the development of standardized pharmacy quality metrics.

CVS Health's HealthHUB locations provide the opportunity for pharmacies to serve as an extension to primary care, the company's chief policy and external affairs officer Tom Moriarty said at the recent Wall Street Project Economic Summit.

Bell and Howell's QuickRx automates the prescription pickup process, freeing pharmacy staff to assist customers.

Adlon Therapeutics' Adhansia XR capsules offer a new option for ADHD patients.